1-3 of 3
Allistair Abraham
Close
Sort by
Journal Articles

Outcomes following posttransplant virus-specific T-cell therapy in patients with sickle cell disease

Clinical Trials & Observations
Hannah Kinoshita, Mamatha Mandava, Mariah Jensen-Wachspress, Haili Lang, Elisabeth Joy, Jay Tanna, Chase D. McCann, Samuel O’Brien, Sianna Burnett, Abeer Shibli, Fahmida Hoq, Monica Bhatia, Patrick J. Hanley, Blachy Dávila Saldaña, Kris M. Mahadeo, Catherine M. Bollard, Michael D. Keller, Allistair Abraham
Journal: Blood Advances
Blood Adv (2023) 7 (10): 2105–2116.
https://doi.org/10.1182/bloodadvances.2022008219
Published: 2023
Includes: Supplemental data
Journal Articles

Reduction in vaso-occlusive events following stem cell transplantation in patients with sickle cell disease

Clinical Trials & Observations
Alexis Leonard, Dana Furstenau, Allistair Abraham, Deepika S. Darbari, Robert S. Nickel, Emily Limerick, Courtney Fitzhugh, Matt Hsieh, John F. Tisdale
Journal: Blood Advances
Blood Adv (2023) 7 (2): 227–234.
https://doi.org/10.1182/bloodadvances.2022008137
Published: 2023
Includes: Supplemental data
Journal Articles

Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine

Clinical Trials & Observations
Andrew C. Harris, Jaap J. Boelens, Kwang Woo Ahn, Mingwei Fei, Allistair Abraham, Andrew Artz, Christopher Dvorak, Haydar Frangoul, Cesar Freytes, Robert Peter Gale, Sanghee Hong, Hillard M. Lazarus, Alison Loren, Shin Mineishi, Taiga Nishihori, Tracey O’Brien, Kirsten Williams, Marcelo C. Pasquini, John E. Levine
Journal: Blood Advances
Blood Adv (2018) 2 (11): 1198–1206.
https://doi.org/10.1182/bloodadvances.2018016956
Published: 2018
Includes: Supplemental data